

LIMITATIONS OF THE TEST
The Influenza A+B Rapid Test is for professional in vitro diagnostic use, and should only be used for the qualitative detection of influenza A and/or B.
2. The etiology of respiratory infection caused by microorganisms other than influenza A or B virus will not be established with this test. The Influenza A+B Rapid Test is capable of detecting both viable and non-viable influenza particles. The performance of the Influenza A+B Rapid Test depends on antigen load and may not correlate with cell culture performed on the same specimen.
3. If the test result is negative and clinical symptoms persist, additional testing using other clinical methods is recommended. A negative result does not at anytime rule out the presence of influenza A and/or B viral antigens in specimen, as they may be present below the minimum detection level of the test. As with all diagnostic tests, a confirmed diagnosis should only be made by a physician after all clinical and laboratory findings have been evaluated.
4. The validity of Influenza A+B Rapid Test has not been proven for identification or confirmation of cell culture isolates.
5. Inadequate or inappropriate specimen collection, storage, and transport may yield false negative test result.
6. Although this test has been shown to detect cultured avian influenza viruses, including avian influenza A subtype H5N1 virus, the performance characteristics of this test with specimens from humans infected with H5N1 or other avian influenza viruses are unknown.
7. Performance characteristics for influenza A were established when influenza A/H3 and A/H1 were the predominant influenza A viruses in circulation.When other
influenza A viruses are emerging, performance characteristics may vary.
8. Children tend to shed virus for longer periods of time than adults, which may result in differences in sensitivity between adults and children.
9. Positive and negative predictive values are highly dependent on prevalence. False positive test results are more likely during periods of low influenza activity when prevalence is moderate to low.
QUALITY CONTROL
Internal procedural controls are not included in the test. A colored band appearing in the control region (C) is considered an internal positive procedural control, confirming sufficient specimen volume and correct procedural technique.
FAQ
Q: What is the flu A&B test?
A: The WELLlife™ COVID-19 / Influenza A&B Test consists of a test cassette that separately detects influenza A, influenza B, and SARS-CoV-2 antigens. The test procedure requires the anterior nasal swab specimen to be inserted into the prefilled extraction buffer tube to be solubilized, and then the specimen is eluted.
Q:What does influenza AB mean?
A: Flu viruses are divided into four types: A, B, C, and D. The primary types affecting humans are flu A and flu B. Which flu is worse, A or B? They cause similar symptoms, but flu A tends to cause more severe illness in adults. The best defense against flu A and B is to get your flu shot each year.
Q:What is influenza type AB?
A:Influenza A is the most common type and usually causes seasonal flu outbreaks. Influenza B can also cause flu outbreaks, but it mutates more slowly.
Q: Which is more serious influenza A or B?
A: Although both influenza A and B viruses predispose children to hospitalization and a wide range of complications, type A viruses are conventionally thought to cause more severe illnesses than B viruses.
Q: How contagious is influenza ab?
A: The incubation period is about 2 days, so it's contagious and hits you quickly. (Not so) Fun fact: flu A is most contagious for the first 24 to 48 hours, but flu B is most contagious 24-48 before symptoms and then AGAIN 24 to 48 hours after.
Hot Tags: influenza ab test kit, China influenza ab test kit manufacturers, suppliers, factory